van Leerdam ME - Search Results

1

The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours.

Clement DSVM, van Leerdam ME, Tesselaar MET, Cananea E, Martin W, Weickert MO, Sarker D, Ramage JK, Srirajaskanthan R. Clement DSVM, et al. Among authors: van leerdam me. J Neuroendocrinol. 2024 Apr;36(4):e13376. doi: 10.1111/jne.13376. Epub 2024 Feb 22. J Neuroendocrinol. 2024. PMID: 38389192

2

Temporal Trends in Body Composition and Metabolic Markers Prior to Diagnosis of Pancreatic Ductal Adenocarcinoma.

Klatte DCF, Weston A, Ma Y, Sledge H, Bali A, Bolan C, Engels M, van Hooft JE, van Leerdam ME, Ouni A, Wallace MB, Bi Y. Klatte DCF, et al. Among authors: van leerdam me. Clin Gastroenterol Hepatol. 2024 May 3:S1542-3565(24)00394-X. doi: 10.1016/j.cgh.2024.03.038. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38703880

3

Optimal resource allocation in colonoscopy: timing of follow-up colonoscopies in relation to adenoma detection rates.

Sint Nicolaas J, de Jonge V, van Baalen O, Kubben FJ, Moolenaar W, Stolk MF, Kuipers EJ, van Leerdam ME; SCoPE consortium. Sint Nicolaas J, et al. Among authors: van baalen o, van leerdam me. Endoscopy. 2013 Jul;45(7):545-52. doi: 10.1055/s-0032-1326359. Epub 2013 Apr 11. Endoscopy. 2013. PMID: 23580411

4

Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant.

Onnekink AM, Klatte DCF, van Hooft JE, van den Berg SH, van der Zwaan SMS, van Doorn R, Hinnen SCH, Potjer TP, Bleiker EMA, van Leerdam ME. Onnekink AM, et al. Among authors: van leerdam me. Fam Cancer. 2024 Jun 1. doi: 10.1007/s10689-024-00401-3. Online ahead of print. Fam Cancer. 2024. PMID: 38822936

5

Germline NPAT inactivating variants as cause of hereditary colorectal cancer.

Terradas M, Schubert SA, Viana-Errasti J, Ruano D, Aiza G, Nielsen M, Marciel P, Tops CM, Parra G, Morreau H, Torrents D, van Leerdam ME, Capellá G, de Miranda NFCC, Valle L, van Wezel T. Terradas M, et al. Among authors: van leerdam me. Eur J Hum Genet. 2024 May 22. doi: 10.1038/s41431-024-01625-8. Online ahead of print. Eur J Hum Genet. 2024. PMID: 38778081

6

When to Start, When to Stop With Colorectal Cancer Screening: A Cost-Effectiveness Analysis.

van de Schootbrugge-Vandermeer HJ, Toes-Zoutendijk E, de Jonge L, van Leerdam ME, Lansdorp-Vogelaar I. van de Schootbrugge-Vandermeer HJ, et al. Among authors: van leerdam me. Gastroenterology. 2024 May 16:S0016-5085(24)04919-9. doi: 10.1053/j.gastro.2024.05.007. Online ahead of print. Gastroenterology. 2024. PMID: 38762073 Free article. No abstract available.

7

Negative screening colonoscopy and long-term colorectal cancer risk-is it time to extend the screening interval?

IJspeert JEG, van Leerdam ME. IJspeert JEG, et al. Among authors: van leerdam me. Lancet Gastroenterol Hepatol. 2024 May 15:S2468-1253(24)00115-8. doi: 10.1016/S2468-1253(24)00115-8. Online ahead of print. Lancet Gastroenterol Hepatol. 2024. PMID: 38761807 No abstract available.

8

Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions.

Boekestijn B, Feshtali S, Vasen H, van Leerdam ME, Bonsing BA, Mieog JSD, Wasser MN. Boekestijn B, et al. Among authors: van leerdam me. Fam Cancer. 2024 May 11. doi: 10.1007/s10689-024-00394-z. Online ahead of print. Fam Cancer. 2024. PMID: 38733421 Review.

9

Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma.

Klatte DCF, Starr JS, Clift KE, Hardway HD, van Hooft JE, van Leerdam ME, Potjer TP, Presutti RJ, Riegert-Johnson DL, Wallace MB, Bi Y. Klatte DCF, et al. Among authors: van leerdam me. JCO Oncol Pract. 2024 Apr 15:OP2300447. doi: 10.1200/OP.23.00447. Online ahead of print. JCO Oncol Pract. 2024. PMID: 38621197

10

Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer.

Bogdanski AM, van Hooft JE, Boekestijn B, Bonsing BA, Wasser MNJM, Klatte DCF, van Leerdam ME. Bogdanski AM, et al. Among authors: van leerdam me. Fam Cancer. 2024 Apr 15. doi: 10.1007/s10689-024-00368-1. Online ahead of print. Fam Cancer. 2024. PMID: 38619782 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

269 results

Search Page